Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of Survival Times of Stage IV Cancer Patients

NCT01843985 is registered in ClinicalTrials.gov with Cure Cancer Worldwide Corporation as lead sponsor.

NCT NCT01843985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01843985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of Survival Times of Stage IV Cancer Patients
Lead sponsor
Cure Cancer Worldwide Corporation
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2013
Completion date
December 31, 2018
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iv cancer (solid tumors only), survival